These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 1434997)

  • 1. [Ferrokinetic studies in the initial evaluation of idiopathic myelofibrosis: results in 18 patients].
    Escoda L; Cervantes F; Pereira A; López-Guillermo A; Piera C; Rozman C
    Med Clin (Barc); 1992 Sep; 99(9):321-3. PubMed ID: 1434997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Idiopathic myelofibrosis: initial features, evolutive patterns and survival in a series of 106 patients].
    Cervantes F; Pereira A; Esteve J; Cobo F; Rozman C; Montserrat E
    Med Clin (Barc); 1997 Nov; 109(17):651-5. PubMed ID: 9488952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ineffective erythropoiesis in myeloid splenomegaly: the 59Fe test, bone marrow histologic and cytologic data].
    Charbord P; Caillou B; Lafleur M; Parmentier C
    Nouv Rev Fr Hematol (1978); 1978 Nov; 20(3):443-53. PubMed ID: 754175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of erythropoiesis activity during hemodialysis therapy by soluble transferrin receptor levels and ferrokinetic measurements.
    Lorenzo JD; Rodríguez MM; Martín SS; Romo JM
    Am J Kidney Dis; 2001 Mar; 37(3):550-6. PubMed ID: 11228179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relevance of bone marrow features in the differential diagnosis between essential thrombocythemia and early stage idiopathic myelofibrosis.
    Thiele J; Kvasnicka HM; Zankovich R; Diehl V
    Haematologica; 2000 Nov; 85(11):1126-34. PubMed ID: 11064463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Compartment analysis in the diagnosis of iron metabolism disorders].
    Konrad H; Neumann J; Esther G; Kiencke H
    Z Gesamte Inn Med; 1981 Mar; 36(5):271-2. PubMed ID: 7245819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ferrokinetic studies and the prognosis of aplastic anaemia].
    Retief FP; Heyns AD; Iturralde M; Lötter MG; Minnaar PC
    S Afr Med J; 1978 Aug; 54(6):235-8. PubMed ID: 715599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Initial iron deposits in idiopathic myelofibrosis. Analysis of 20 patients].
    Cervantes F; López-Guillermo A; Piera C; Pereira A; Aguilar JL; Ordi J; Rozman C
    Sangre (Barc); 1993 Aug; 38(4):279-82. PubMed ID: 8235941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radio-iron kinetic studies in anaemia and the measurement of dyserythropoiesis.
    Najean Y; Deschryver F; Dresch C
    Nouv Rev Fr Hematol (1978); 1988; 30(3):167-75. PubMed ID: 3419896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Danazol treatment of idiopathic myelofibrosis with severe anemia.
    Cervantes F; Hernández-Boluda JC; Alvarez A; Nadal E; Montserrat E
    Haematologica; 2000 Jun; 85(6):595-9. PubMed ID: 10870115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythroid bone marrow activity and red cell hemoglobinization in iron sufficient beta-thalassemia heterozygotes as reflected by soluble transferrin receptor and reticulocyte hemoglobin in content. Correlation with genotypes and Hb A(2) levels.
    Skarmoutsou C; Papassotiriou I; Traeger-Synodinos J; Stamou H; Ladis V; Metaxotou-Mavrommati A; Stamoulakatou A; Kanavakis E
    Haematologica; 2003 Jun; 88(6):631-6. PubMed ID: 12801838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. rHuEpo for the treatment of anemia in myelofibrosis with myeloid metaplasia. Experience in 6 patients and meta-analytical approach.
    Rodríguez JN; Martino ML; Diéguez JC; Prados D
    Haematologica; 1998 Jul; 83(7):616-21. PubMed ID: 9718866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies of iron kinetics using a linear scanner. I. Distribution of sites of uptake of plasma iron in hematological disorders.
    Alfrey CP; Lynch EC; Hettig RA
    J Lab Clin Med; 1969 Mar; 73(3):405-17. PubMed ID: 5766186
    [No Abstract]   [Full Text] [Related]  

  • 14. Ferrokinetic study of splenic erythropoiesis: relationships among clinical diagnosis, myelofibrosis, splenomegaly, and extramedullary erythropoiesis.
    Beguin Y; Fillet G; Bury J; Fairon Y
    Am J Hematol; 1989 Oct; 32(2):123-8. PubMed ID: 2757009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative ferrokinetic study with initial and extended iron clearance models.
    Howarth JE; Waters HM; Hyde K; Shanks D; Geary CG
    J Clin Pathol; 1991 May; 44(5):395-9. PubMed ID: 2045499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma fibronectin in idiopathic myelofibrosis and related chronic myeloproliferative disorders.
    Hasselbalch H; Clemmensen I
    Scand J Clin Lab Invest; 1987 Sep; 47(5):429-33. PubMed ID: 3477850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Idiopathic myelofibrosis].
    Saad GM; de Almeida TV
    Rev Paul Med; 1991; 109(2):47-50. PubMed ID: 1887177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic idiopathic myelofibrosis: prognostic impact of myelofibrosis and clinical parameters on event-free survival in 122 patients who presented in prefibrotic and fibrotic stages. A retrospective study identifying subgroups of different prognoses by using the RECPAM method.
    Kreft A; Weiss M; Wiese B; Choritz H; Buhr T; Büsche G; Georgii A
    Ann Hematol; 2003 Oct; 82(10):605-11. PubMed ID: 14564478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Incidence of neoplasms in non-congenital refractory anemias. Ferrokinetic pattern].
    Abadía MF; Ramírez R; Sarasola A; Navarro Izquierdo AL
    Rev Esp Oncol; 1984; 31(3):483-90. PubMed ID: 6546177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Idiopathic myelofibrosis: a retrospective study of 103 patients.
    Anger B; Seidler R; Haug U; Popp C; Heimpel H
    Haematologica; 1990; 75(3):228-34. PubMed ID: 2227619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.